IL-17 in Systemic Lupus Erythematosus

DSpace/Manakin Repository

IL-17 in Systemic Lupus Erythematosus

Citable link to this page

. . . . . .

Title: IL-17 in Systemic Lupus Erythematosus
Author: Crispín, José C.; Tsokos, George C.

Note: Order does not necessarily reflect citation order of authors.

Citation: Crispín, José C., and George C. Tsokos. 2010. IL-17 in systemic lupus erythematosus. Journal of Biomedicine and Biotechnology 2010: 943254.
Full Text & Related Files:
Abstract: IL-17 is a cytokine with powerful proinflammatory activity. Production of IL-17 is abnormally increased in patients with systemic lupus erythematosus (SLE), a multiorgan chronic autoimmune disease. In patients with SLE, CD3+CD4−CD8− (double negative) T cells are an important source of IL-17. IL-17 produced by double negative and CD4 T cells participates in the pathogenesis of the disease. IL-17-producing T cells are present in the kidneys of patients with lupus nephritis. IL-17 increased production in patients with SLE can amplify the immune response by increasing target organ inflammation and damage and by augmenting the production of antibodies by B cells.
Published Version: doi:10.1155/2010/943254
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850519/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4739309

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters